Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arunkumar Manoharan
Institution:
Suven Life Sciences (India)
Observed institution:
Suven Life Sciences (India)
OpenAlex ID:
A5109202977
Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays
2014
·
Ramakrishna Nirogi
, Raghava Choudary Palacharla
, et al.
·
Xenobiotica
·
40
Inhibition of cytochrome P450 enzymes by saturated and unsaturated fatty acids in human liver microsomes, characterization of enzyme kinetics in the presence of bovine serum albumin (0.1 and 1.0% w/v) and in vitro – in vivo extrapolation of hepatic clearance
2017
·
Raghava Choudary Palacharla
, Venkatesham Uthukam
, et al.
·
European Journal of Pharmaceutical Sciences
·
19
Quantitativein vitrophenotyping and prediction of drug interaction potential of CYP2B6 substrates as victims
2017
·
Raghava Choudary Palacharla
, Ramakrishna Nirogi
, et al.
·
Xenobiotica
·
17
Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction
2015
·
Ramakrishna Nirogi
, Raghava Choudary Palacharla
, et al.
·
Chemico-Biological Interactions
·
13
Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy
2020
·
Ramakrishna Nirogi
, Gopinadh Bhyrapuneni
, et al.
·
European Journal of Pharmaceutical Sciences
·
12
Mechanistic evaluation of tapentadol in reducing the pain perception using in-vivo brain and spinal cord microdialysis in rats
2017
·
Vijay Benade
, Ramakrishna Nirogi
, et al.
·
European Journal of Pharmacology
·
12
Effect of Dimethyl Sulfoxide on In Vitro Cytochrome P4501A2 Mediated Phenacetin O-Deethylation in Human Liver Microsomes
2011
·
Ramakrishna Nirogi
, Vishwottam Kandikere
, et al.
·
Drug Metabolism and Disposition
·
11
Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders
2021
·
Ramakrishna Nirogi
, Venkata R Grandhi
, et al.
·
Journal of Psychopharmacology
·
9
P1‐310: Suvn‐g3031, an h3 receptor inverse agonist, produces procognitive effects without affecting sleep in preclinical models
2015
·
Vijay S. Benade
, Saivishal Daripelli
, et al.
·
Alzheimer s & Dementia
·
4
P1‐398: Suvn‐d4010: Novel 5‐ht4 Receptor Partial Agonist for the Treatment of Alzheimer's Disease
2014
·
Nageswararao Muddana
, Ramkumar Subramanian
, et al.
·
Alzheimer s & Dementia
·
3
PDF
The use of inactivated brain homogenate to determine the in vitro fraction unbound in brain for unstable compounds
2020
·
Ramakrishna Nirogi
, Parusharamulu Molgara
, et al.
·
Xenobiotica
·
2
P4‐211: Effects of Norepinephrine Reuptake Inhibitors on Neurotransmitter Modulations Associated With Cognitive Dysfunction in Chronic Pain
2014
·
Vijay S. Benade
, Gopinadh Bhyrapuneni
, et al.
·
Alzheimer s & Dementia
P4‐235: Pro‐cognitive properties of SUVN‐G1010034, a potent selective H3 antagonist in animal models of cognition
2012
·
Ramakrishna Nirogi
, Vishwottam Kandikere
, et al.
·
Alzheimer s & Dementia
P1‐263: Pro‐cognitive properties SUVN‐D1108121, a potent and selective 5‐HT4 receptor partial agonist
2012
·
Ramakrishna Nirogi
, Renny Abraham
, et al.
·
Alzheimer s & Dementia
P3‐450: Neurochemical profile of SUVN‐G1031, a novel histamine H3 receptor antagonist
2011
·
Nageswararao Muddana
, Vishwottam Kandikere
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
16
Citation count:
143
H-index:
8
I10-index:
7
Year
Topic
Type